245 related articles for article (PubMed ID: 31880916)
1. Combined
Zang J; Liu Q; Sui H; Guo H; Peng L; Li F; Lang L; Jacobson O; Zhu Z; Mao F; Chen X
Bioconjug Chem; 2020 Feb; 31(2):396-403. PubMed ID: 31880916
[TBL] [Abstract][Full Text] [Related]
2. Within-patient comparison between [
Mahieu R; Donders DNV; Krijger GC; Ververs FFT; de Roos R; Bemelmans JLMM; van Rooij R; de Bree R; de Keizer B
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2023-2036. PubMed ID: 34962582
[TBL] [Abstract][Full Text] [Related]
3. Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.
Ankersmit M; Hoekstra OS; van Lingen A; Bloemena E; Jacobs MAJM; Vugts DJ; Bonjer HJ; van Dongen GAMS; Meijerink WJHJ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1495-1505. PubMed ID: 30798428
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node detection in thyroid carcinoma using [
de Vries LH; Lodewijk L; Ververs T; Poot AJ; van Rooij R; Brosens LAA; de Krijger RR; Rinkes IHMB; Vriens MR; de Keizer B
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):512-520. PubMed ID: 37773437
[TBL] [Abstract][Full Text] [Related]
5.
Savolainen H; Volpe A; Phinikaridou A; Douek M; Fruhwirth G; de Rosales RTM
Nanotheranostics; 2019; 3(3):255-265. PubMed ID: 31263657
[TBL] [Abstract][Full Text] [Related]
6.
Hou G; Jiang Y; Xu W; Zhu Z; Huo L; Chen X; Li F; Xu KF; Cheng W
Orphanet J Rare Dis; 2021 Jun; 16(1):279. PubMed ID: 34134735
[TBL] [Abstract][Full Text] [Related]
7. Assessing
Sarikaya I; Sarikaya A
J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
[No Abstract] [Full Text] [Related]
8. A First-in-Human Study of
Doughton JA; Hofman MS; Eu P; Hicks RJ; Williams S
J Nucl Med; 2018 Dec; 59(12):1837-1842. PubMed ID: 29728517
[TBL] [Abstract][Full Text] [Related]
9. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
[TBL] [Abstract][Full Text] [Related]
10. Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy.
Christin OL; Kuten J; Even-Sapir E; Klausner J; Menes TS
Surg Oncol; 2019 Sep; 30():1-5. PubMed ID: 31500769
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the diagnostic value of preoperative sentinel lymph node (SLN) imaging in penile carcinoma patients without palpable inguinal lymph nodes via single photon emission computed tomography/computed tomography (SPECT/CT) as compared to planar scintigraphy.
Naumann CM; Colberg C; Jüptner M; Marx M; Zhao Y; Jiang P; Hamann MF; Jünemann KP; Zuhayra M; Lützen U
Urol Oncol; 2018 Mar; 36(3):92.e17-92.e24. PubMed ID: 29249274
[TBL] [Abstract][Full Text] [Related]
13.
Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
[TBL] [Abstract][Full Text] [Related]
14. Clinical Evaluation of 99mTc-Rituximab for Sentinel Lymph Node Mapping in Breast Cancer Patients.
Li N; Wang X; Lin B; Zhu H; Liu C; Xu X; Zhang Y; Zhai S; OuYang T; Li J; Yang Z
J Nucl Med; 2016 Aug; 57(8):1214-20. PubMed ID: 26985055
[TBL] [Abstract][Full Text] [Related]
15. "Sentinel lymph node imaging with sequential SPECT/CT lymphoscintigraphy before and after neoadjuvant chemoradiotherapy in patients with cancer of the oesophagus or gastro-oesophageal junction - a pilot study".
Gabrielson S; Tsai JA; Celebioglu F; Nilsson M; Rouvelas I; Lindblad M; Bjäreback A; Tomson A; Axelsson R
Cancer Imaging; 2018 Dec; 18(1):53. PubMed ID: 30563571
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
17. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.
Hellingman D; de Wit-van der Veen BJ; Wan OY; van der Ploeg IM; Rutgers EJT; Stokkel MPM
J Surg Oncol; 2019 Mar; 119(4):421-429. PubMed ID: 30582611
[TBL] [Abstract][Full Text] [Related]
19. Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
Magnoni F; Corso G; Gilardi L; Pagan E; Massari G; Girardi A; Ghidinelli F; Bagnardi V; Galimberti V; Grana CM; Veronesi P
Future Oncol; 2022 Jan; 18(2):193-204. PubMed ID: 34882010
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node approach in prostate cancer.
Vidal-Sicart S; Valdés Olmos RA
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):358-71. PubMed ID: 26391573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
